Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3004)
All Articles published online
|
Oct 21, 2008 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee CF, Ling ZQ, Zhao T, Lee KR. Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma. World J Gastroenterol 2008; 14(39): 6072-6077 [PMID: 18932288 DOI: 10.3748/wjg.14.6072] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i39/6072.htm |
| Number | Citing Articles |
| 1 |
Rosina Maria Critelli, Nicola De Maria, Erica Villa. Biology of Hepatocellular Carcinoma. Digestive Diseases 2015; 33(5): 635 doi: 10.1159/000438472
|
| 2 |
Yangyang Hu, Shengpeng Wang, Xu Wu, Jinming Zhang, Ruie Chen, Meiwan Chen, Yitao Wang. Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma. Journal of Ethnopharmacology 2013; 149(3): 601 doi: 10.1016/j.jep.2013.07.030
|
| 3 |
Hiroki Ryuno, Isao Naguro, Miki Kamiyama. ASK family and cancer. Advances in Biological Regulation 2017; 66: 72 doi: 10.1016/j.jbior.2017.05.003
|
| 4 |
Jessica McArdle, Nathaniel J. Moorman, Joshua Munger, James C. Alwine. HCMV Targets the Metabolic Stress Response through Activation of AMPK Whose Activity Is Important for Viral Replication. PLoS Pathogens 2012; 8(1): e1002502 doi: 10.1371/journal.ppat.1002502
|
| 5 |
Qing Zhong, Xuan An, Yi‐Xuan Yang, Huai‐Dong Hu, Hong Ren, Peng Hu. Keratin 8 is involved in hepatitis B virus replication. Journal of Medical Virology 2014; 86(4): 687 doi: 10.1002/jmv.23873
|
| 6 |
Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park. Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease. Clinical and Molecular Hepatology 2015; 21(3): 279 doi: 10.3350/cmh.2015.21.3.279
|
| 7 |
Hao Xiong, Juliet Morrison, Martin T Ferris, Lisa E Gralinski, Alan C Whitmore, Richard Green, Matthew J Thomas, Jennifer Tisoncik-Go, Gary P Schroth, Fernando Pardo-Manuel de Villena, Ralph S Baric, Mark T Heise, Xinxia Peng, Michael G Katze. Genomic Profiling of Collaborative Cross Founder Mice Infected with Respiratory Viruses Reveals Novel Transcripts and Infection-Related Strain-Specific Gene and Isoform Expression. G3 Genes|Genomes|Genetics 2014; 4(8): 1429 doi: 10.1534/g3.114.011759
|
| 8 |
Adam Pickard, Dennis J. McCance. IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?. Frontiers in Endocrinology 2015; 6 doi: 10.3389/fendo.2015.00025
|
| 9 |
Wendy El Khoury, Zeina Nasr. Deregulation of ribosomal proteins in human cancers. Bioscience Reports 2021; 41(12) doi: 10.1042/BSR20211577
|
| 10 |
Yong-Song Guan, Qing He. Role of antiviral therapy in the management of hepatocellular carcinoma. Anti-Cancer Drugs 2013; 24(4): 337 doi: 10.1097/CAD.0b013e32835ec39a
|
| 11 |
A. V. Snezhkina, E. N. Lukyanova, M. S. Fedorova, D. V. Kalinin, N. V. Melnikova, O. A. Stepanov, M. V. Kiseleva, A. D. Kaprin, E. A. Pudova, A. V. Kudryavtseva. Novel Genes Associated with the Development of Carotid Paragangliomas. Molecular Biology 2019; 53(4): 547 doi: 10.1134/S0026893319040137
|
| 12 |
Yu-Yun Shao, Wen-Yi Shau, Soa-Yu Chan, Li-Chun Lu, Chih-Hung Hsu, Ann-Lii Cheng. Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials. Oncology 2015; 88(6): 345 doi: 10.1159/000369559
|
| 13 |
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival. World Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
|
| 14 |
Ambreen Ayub, Usman Ali Ashfaq, Asma Haque. HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/810461
|
| 15 |
Tao Li, M. Elizabeth Forbes, Gregory N. Fuller, Jiabo Li, Xuejun Yang, Wei Zhang. IGFBP2: integrative hub of developmental and oncogenic signaling network. Oncogene 2020; 39(11): 2243 doi: 10.1038/s41388-020-1154-2
|
| 16 |
Wen-Shu Chen, Chia-Jui Yen, Yun-Ju Chen, Jhen-Yu Chen, Li-Yun Wang, Shu-Jun Chiu, Wen-Ling Shih, Chien-Yi Ho, Tzu-Tang Wei, Hsiao-Lin Pan, Pei-Hsuan Chien, Mien-Chie Hung, Ching-Chow Chen, Wei-Chien Huang. miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin. Oncotarget 2015; 6(28): 25962 doi: 10.18632/oncotarget.4504
|
| 17 |
Xinhong Zhang, Boyan Zhang, Yawei Zhang, Fan Zhang. Association analysis of hepatocellular carcinoma‐related hub proteins and hub genes. PROTEOMICS – Clinical Applications 2023; 17(5) doi: 10.1002/prca.202200090
|
| 18 |
Guanyu Wang, Fulu Dong, Zhiyao Xu, Sherven Sharma, Xiaotong Hu, Dafang Chen, Lumin Zhang, Jinping Zhang, Qinghua Dong. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3816-1
|
| 19 |
Fei Ye, Zhongshuai Xin, Wei Han, Jingjing Fan, Bin Yin, Shuzhen Wu, Wei Yang, Jiangang Yuan, Boqin Qiang, Wei Sun, Xiaozhong Peng, Koichi Watashi. Quantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell Lines. PLOS ONE 2015; 10(11): e0142082 doi: 10.1371/journal.pone.0142082
|
| 20 |
Ming-Chin Yu, Yun-Shien Lee, Sey-En Lin, Hsiang-Yao Wu, Tse-Ching Chen, Wei-Chen Lee, Miin-Fu Chen, Chi-Neu Tsai. Recurrence and Poor Prognosis Following Resection of Small Hepatitis B-Related Hepatocellular Carcinoma Lesions Are Associated with Aberrant Tumor Expression Profiles of Glypican 3 and Osteopontin. Annals of Surgical Oncology 2012; 19(S3): 455 doi: 10.1245/s10434-011-1946-2
|
| 21 |
Alla Arzumanyan, Helena M. G. P. V. Reis, Mark A. Feitelson. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nature Reviews Cancer 2013; 13(2): 123 doi: 10.1038/nrc3449
|
| 22 |
Wei Sun, Fan Zhong, Lianteng Zhi, Gangqiao Zhou, Fuchu He. Systematic -omics analysis of HBV-associated liver diseases. Cancer Letters 2009; 286(1): 89 doi: 10.1016/j.canlet.2008.12.002
|
| 23 |
Bu-Yeo Kim, Dong Wook Choi, Seon Rang Woo, Eun-Ran Park, Je-Geun Lee, Su-Hyeon Kim, Imhoi Koo, Sun-Hoo Park, Chul Ju Han, Sang Bum Kim, Young Il Yeom, Suk-Jin Yang, Ami Yu, Jae Won Lee, Ja June Jang, Myung-Haing Cho, Won Kyung Jeon, Young Nyun Park, Kyung-Suk Suh, Kee-Ho Lee. Recurrence-associated pathways in hepatitis B virus-positive hepatocellular carcinoma. BMC Genomics 2015; 16(1) doi: 10.1186/s12864-015-1472-x
|
| 24 |
Sarwat Fatima, John M Luk, Ronnie TP Poon, Nikki P Lee. Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2014; 14(5): 535 doi: 10.1586/14737159.2014.915747
|
| 25 |
Lohit Khera, Catherine Paul, Rajeev Kaul. Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1. Virology 2017; 506: 110 doi: 10.1016/j.virol.2017.03.014
|
| 26 |
Sarwat Fatima, Xiaoke Shi, Zesi Lin, Guo-qing Chen, Xiao-hua Pan, Justin Che-Yuen Wu, John W. Ho, Nikki P. Lee, Hengjun Gao, Ge Zhang, Aiping Lu, Zhao Xiang Bian. 5‐Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β‐catenin. Molecular Oncology 2016; 10(2): 195 doi: 10.1016/j.molonc.2015.09.008
|
| 27 |
Sun Young Lee, Kwang Hoon Song, Imhoi Koo, Kee-Ho Lee, Kyung-Suk Suh, Bu-Yeo Kim. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method. Genomics 2012; 99(6): 347 doi: 10.1016/j.ygeno.2012.04.004
|